Emirates Hospital / CosmeSurge




CosmeSurge works closely with Emirates Hospital for the treatment of breast cancer

 

CosmeSurge cooperates daily with Emirates Hospital specialists who are part of their Breast Program. Dr Dora Evangelidou, the Plastic and Reconstructive Surgeon at CosmeSurge, said: “It is shown by many studies that the basis of excellence in breast cancer treatment and recovery is the care given by a multidisciplinary team.”

“When a patient needs a removal of the breast or even breast conserving surgery, in most cases we offer immediate reconstruction using techniques tailored to the individual. Our breast surgeons cooperate with plastic-reconstructive surgeons to get the best cosmetic results,” he said.

“Breast reconstruction, frequently begins at the time of removal of the breast. In our hands, each patient discusses her reconstructive options with her plastic surgeon before surgery. Our policy at Cosme- Surge and Emirates Hospital is to ensure complete awareness of breast reconstruction options and this can be achieved with a single visit to our Plastic and Reconstructive Surgery department. Our breast surgeon and our reconstructive surgeon will then make a coordinated plan for each patient’s treatment.”

Usually, the two main choices are between using the patient’s own tissue for reconstruction or using implants. Frequently implant reconstruction is performed in two stages starting with an expander at the time of removal of the breast. Less frequently and if a small breast is desired, a permanent implant is placed at the time of the removal of the breast.

“We always advise patients to see a plastic surgeon about reconstruction as soon as she considers treatment that includes the possibility of surgery to remove a breast. It is also possible to see a plastic surgeon after they have begun or even completed treatment for breast cancer. However, some options are best if carried out with cooperation between the surgeon who removes the breast and the surgeon who will begin reconstruction at the time of removal of the breast.”

Dr Evangelidou added: “Often when we hear about plastic surgery, we think of cosmetic procedures such as tummy tuck andbreast augmentation, but it should be remembered that the fi eld of plastic surgery also focuses on reconstruction. Actually, reconstructive plastic surgery is the root and the backbone of what we know today as cosmetic surgery. It is really impressive how a simple reconstructive procedure has the power to improve a life. That is indeed priceless.”

 

Breast Cancer

Breast cancer is the most common cancer in women. One in eight women will be diagnosed with breast cancer over the course of her lifetime. Breast cancer which is diagnosed in the early stages can be treated successfully. A woman’s risk of breast cancer increases if she has a fi rst-degree relative (mother, sister, daughter) who has breast cancer history.

About 5-10% of breast cancers can be linked to gene mutations (abnormal changes) inherited from one’s mother or father. Mutations of the BRCA1 and BRCA2 genes are the most common. About 85% of breast cancers occur in women who have no family history of breast cancer. Symptoms of breast cancer include: a lump in the breast, swelling of the breast, skin irritation or dimpling, breast pain, the nipple turning inward, redness or thickening of skin on the breast, a bloody or clear nipple discharge other than breast milk, or a lump in the underarm area.

It’s important to get any changes in the breast diagnosed promptly by a breast surgeon. Early breast cancer diagnosis increases the chance of a successful treatment. Regular screening, increased awareness helps with this.

Surgery is usually the first-line treatment of breast cancer. The patient and surgeon decide together on the type of surgery based on the disease stage and tumour characteristics. Breast conserving surgery is also an option in some cases. Chemotherapy and radiation therapy can be used to destroy cancer cells that may remain in the breast after surgery. Hormonal therapy is used to treat hormone-receptor-positive breast cancers by reducing the amount of estrogen or blocking its action.

 

 
Date of upload: 18th Jul 2017

                                  
                                               Copyright © 2017 MiddleEastHealthMag.com. All Rights Reserved.